Seksyen 1
Perintah ini bolehlah dinamakan Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019.
/akn/my/act/pua/2019/202
The full official text, structured for quick navigation. Copy any provision or jump straight to a section.
Quick answer
PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 2) 2019 is Malaysia P.U. (A), cited as P.U. (A) 202 2019, currently marked in force and first recorded in 2019.
Opening note
Perintah ini bolehlah dinamakan Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019.
Pindaan Jadual Pertama
dalam senarai “Antihistamines; the following:”, dengan memasukkan selepas butiran “Doxylamine” butiran
“Ebastine”;
dengan memasukkan selepas butiran “Bretylium; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:
P.U. (A) 202 3
Names Part I Part II Exempt
Group A Group B Group C Group D
“Brexpiprazole - All preparations”;
dengan memasukkan selepas butiran “Chlorzoxazone” dan butir-butir yang berhubungan dengannya butiran yang berikut:
Names Part I
“Cholecalciferol -
All medicinal preparations containing 10,000 i.u. or more of cholecalciferol per dosage unit
All preparations for parenteral administration unless in
Group B
-
-
All preparations unless in Group B or Group C”;
P.U. (A) 202 4
dengan memasukkan selepas butiran “Duloxetine; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:
Names
Bahagian I
Bahagian II
Group A
Group B
Group C
Group D
“Dupilumab
-
All preparations
Durvalumab
-
All preparations”;
dengan menggantikan butiran
“3,4-Methylenedioxy-methamphetamine
(MDMA)(DD)”
dengan butiran
“3,4-Methylenedioxymethamphetamine (MDMA)(DD)”;
dengan memasukkan selepas butiran “Pomalidomide” dan butir-butir yang berhubungan dengannya butiran yang berikut:
Names
Group A
Group B
Group C
Group D
“Ponatinib
-
All preparations”;
P.U. (A) 202 5
dengan memasukkan selepas butiran “Santonin” dan butir-butir yang berhubungan dengannya butiran yang berikut:
Names
Group A
Group B
Group C
Group D
“Sapropterin
-
All preparations”; dan
dalam senarai “Vitamins; the following:”, dengan memotong butiran “Cholecalciferol”; dan
dalam senarai “Antihistamines:”, dengan memasukkan selepas butiran “Doxylamine” butiran “Ebastine”;
dengan memasukkan selepas butiran “Pomalidomide” butiran “Ponatinib”;
P.U. (A) 202 6
dalam senarai “Dermatological agents:”, dengan memasukkan selepas butiran “Dithranol” butiran “Dupilumab”;
dalam senarai “Tranquillisers:”, dengan memasukkan selepas butiran “Benzquinamide” butiran “Brexpiprazole”;
dan
dalam senarai “Miscellaneous:”, dengan memasukkan selepas butiran “Sabadilla, alkaloids of” butiran “Sapropterin”.
Dibuat 25 Jun 2019
[KKM.R.600-1/1/56 JLD.(4)(9); PN(PU2)172/XVII]
DATUK SERI DR. DZULKEFLY BIN AHMAD
Menteri Kesihatan
P.U. (A) 202 7
POISONS ACT 1952
POISONS (AMENDMENT OF POISONS LIST) (NO. 2) ORDER 2019
Opening note
in the list of “Antihistamines; the following:”, by inserting after the item “Doxylamine” the item “Ebastine”;
by inserting after the item “Bretylium; its salts” and the particulars relating to it the following item:
P.U. (A) 202 8
Names Part I Part II Exempt
Group A Group B Group C Group D
“Brexpiprazole - All preparations”;
by inserting after the item “Chlorzoxazone” and the particulars relating to it the following item:
Name
Group A
Group B
Group C
Group D
“Cholecalciferol -
All medicinal preparations containing 10,000 i.u. or more of cholecalciferol per dosage unit
All preparations for parenteral administration unless in
Group B
-
-
All preparations unless in Group B or Group C”;
P.U. (A) 202 9
by inserting after the item “Duloxetine; its salts” and the particulars relating to it the following item:
Names
Group A
Group B
Group C
Group D
“Dupilumab
-
All preparations
Durvalumab
-
All preparations”;
by substituting for the item
“3,4-Methylenedioxy-methamphetamine
(MDMA)(DD)”
the item
“3,4-Methylenedioxymethamphetamine (MDMA)(DD)”;
by inserting after the item “Pomalidomide” and the particulars relating to it the following item:
Names
Group A
Group B
Group C
Group D
“Ponatinib
-
All preparations”;
P.U. (A) 202 10
by inserting after the item “Santonin” and the particulars relating to it the following item:
Names
Group A
Group B
Group C
Group D
“Sapropterin
-
All preparations”; and
in the list of “Vitamins; the following:”, by deleting the item “Cholecalciferol”; and
in the list of “Antihistamines:”, by inserting after the item “Doxylamine” the item “Ebastine”;
by inserting after the item “Pomalidomide” the item “Ponatinib”;
in the list of “Dermatological agents:”, by inserting after the item “Dithranol” the item “Dupilumab”;
P.U. (A) 202 11
in the list of “Tranquillisers:”, by inserting after the item “Benzquinamide” the item “Brexpiprazole”; and
in the list of “Miscellaneous:”, by inserting after the item “Sabadilla, alkaloids of” the item “Sapropterin”.
Made 25 June 2019
[KKM.R.600-1/1/56 JLD.(4)(9); PN(PU2)172/XVII]
DATUK SERI DR. DZULKEFLY BIN AHMAD
Minister of Health